Literature DB >> 16168199

Drug-induced acute autoimmune hepatitis during combination therapy with atorvastatin and ezetimibe.

Charles van Heyningen1.   

Abstract

A case is presented of a patient who developed acute hepatitis during cholesterol-lowering treatment with atorvastatin and ezetimibe. Further investigations reveal a probable drug-induced autoimmune hepatitis, and ezetimibe is considered to be the most likely causal agent. This case is the first report of an autoimmune hepatitis associated with ezetimibe therapy.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16168199     DOI： 10.1258/0004563054890105

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN： 0004-5632            Impact factor:   2.057


  9 in total

1.  Drug-induced liver injury associated with ezetimibe therapy.

Authors:  Qiang Liu; Hillel Tobias; Lydia M Petrovic
Journal:  Dig Dis Sci       Date:  2007-01-12       Impact factor: 3.199

2.  Steroid use in acute liver failure.

Authors:  Jamuna Karkhanis; Elizabeth C Verna; Matthew S Chang; R Todd Stravitz; Michael Schilsky; William M Lee; Robert S Brown
Journal:  Hepatology       Date:  2013-12-24       Impact factor: 17.425

3.  Ezetimibe inhibits expression of acid sphingomyelinase in liver and intestine.

Authors:  Yajun Cheng; Fuli Liu; Jun Wu; Yao Zhang; Ake Nilsson; Rui-Dong Duan
Journal:  Lipids       Date:  2009-09-24       Impact factor: 1.880

4.  Serious drug-induced liver disease secondary to ezetimibe.

Authors:  José Castellote; Javier Ariza; Rosa Rota; Anna Girbau; Xavier Xiol
Journal:  World J Gastroenterol       Date:  2008-08-28       Impact factor: 5.742

Review 5.  Lipid-lowering agents that cause drug-induced hepatotoxicity.

Authors:  Sidharth S Bhardwaj; Naga Chalasani
Journal:  Clin Liver Dis       Date:  2007-08       Impact factor: 6.126

Review 6.  Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanism.

Authors:  Beatrice A Golomb; Marcella A Evans
Journal:  Am J Cardiovasc Drugs       Date:  2008       Impact factor: 3.571

Review 7.  Drug-induced autoimmune-like hepatitis.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2011-02-16       Impact factor: 3.487

8.  High Dose Atorvastatin Associated with Increased Risk of Significant Hepatotoxicity in Comparison to Simvastatin in UK GPRD Cohort.

Authors:  Alan T Clarke; Paul C D Johnson; Gillian C Hall; Ian Ford; Peter R Mills
Journal:  PLoS One       Date:  2016-03-16       Impact factor: 3.240

9.  Recurrence and Severe Worsening of Hepatotoxicity After Reintroduction of Atorvastatin in Combination With Ezetimibe.

Authors:  Silje Bergland Ellingsen; Elisabet Nordmo; Knut Tore Lappegård
Journal:  Clin Med Insights Case Rep       Date:  2017-09-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.